Home  /  Resource Library  /  Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission

Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission

Study compared autologous stem cell transplant with CAR T therapy for second line treatment of diffuse large b-cell lymphoma.